AXTI earnings analysis
What we found in AXTI's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
AXT delivered a sharp Q2 rebound, with revenue of $47.589 million versus $27 million in Q1 2026 and $18 million in Q2 2025, while diluted EPS improved to $0.19 from losses in both comparison periods. The principal financial overhang is the approximately $49 million Tongmei redemption exposure following withdrawal of its IPO application. Export-permit uncertainty, expanded PRC trade-control authority and ongoing litigation remain material risks, although management states that it has sufficient funds to satisfy a full redemption and that disclosure controls were effective.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Strong Q2 Revenue and EPS Rebound
- Q2 2026 revenue was $47.589 million, up from $27 million in Q1 2026 and $18 million in Q2 2025, while diluted EPS improved to $0.19 from $(0.03) and $(0.16), respectively.
- Liquidity Covers Potential Redemption
- The company stated that it has sufficient funds to redeem the Tongmei investors' interests in full if required; the aggregate redemption amount is approximately $49 million.
- Supply-Chain Investments Remain Material
- Minority investments in Chinese raw-material companies totaled $14.1 million at June 30, 2026, compared with $15.0 million at December 31, 2025, a $0.9 million reduction.
- Lower Receivables Concentration
- No customer represented more than 10% of accounts receivable at June 30, 2026, compared with one customer above 10% at December 31, 2025, indicating lower receivables concentration.
- Effective Disclosure Controls
- Management concluded that disclosure controls and procedures were effective at the reasonable-assurance level as of June 30, 2026, and reported no material changes in internal control during the quarter.
- Reduced U.S. Revenue and Tariff Exposure
- North American sales represented approximately 2% of 2025 revenue versus 8% in 2024, while tariffs paid declined to approximately $0.3 million in 2025 from $1.0 million in both 2024 and 2023.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Tongmei Redemption Obligation
- Tongmei's July 8, 2026 IPO withdrawal triggered redemption rights for investors. The aggregate redemption amount is approximately $49 million, and the U.S.-dollar payment will vary with the RMB/USD exchange rate.
- China Export Permit Uncertainty
- All wafer substrates are manufactured in China, and three wafer-substrate product families require Ministry of Commerce permits before export. InP permits remain uncertain, while no permits for gallium arsenide exports to U.S. customers had been approved as of the report.
- Expanded PRC Trade Restrictions
- The revised Foreign Trade Law became effective March 1, 2026 and gives Chinese agencies enhanced power to restrict imports and exports. The filing states that additional restrictions cannot be ruled out.
- Continuing Securities Litigation
- The shareholder class action was dismissed twice but received leave to amend; the plaintiff filed a third amended complaint on August 4, 2026. The company states that the ultimate outcome and any loss range cannot currently be estimated.
- Foreign-Exchange Volatility
- The company recorded foreign-exchange losses of $74,000 in 2025 after gains of $91,000 in 2024 and $169,000 in 2023. Its hedging program primarily covers Japanese yen and may not fully mitigate currency exposure.
- Gross-Margin Volatility
- Management disclosed gross margin volatility from product mix, yields, utilization, raw-material costs and tariffs; historical gross margin ranged from negative 6.4% in Q1 2025 to 22.3% in Q3 2025.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.19
What they said about what is next.
No numeric revenue or EPS outlook was provided in the extracted 10-Q; the filing refers generally to public guidance but does not state quantitative quarterly guidance.
The filing reads better than the one before it.
What came before.
- 10-Q · May 14, 2026
- AXT, Inc. reported Q1 2026 revenue of $26.9 million, a 39.1% increase year-over-year, driven primarily by demand for InP wafer substrates. The company narrowed its EPS loss to -$0.03 from -$0.20 in the prior year,…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing AXTI makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever